Supernus Pharmaceuticals

Supernus Pharmaceuticals

World Rank (Aug-2026)
5237
Market Cap (Aug-2026)
2.806 Billion USD
Market Cap (Mar-08-2026)
3.095 Billion USD
World Rank (Jan-05-2024)
6,703
Market Cap (Jan-05-2024)
1.522 Billion USD
World Rank (Jul-30-2023)
6,453
Market Cap (Jul-30-2023)
1.657 Billion USD
World Rank (Jan-07-2022)
7,241
Market Cap (Jan-07-2022)
1.581 Billion USD
World Rank (Jan-01-2021)
6,859
Market Cap (Jan-01-2021)
1.313 Billion USD
Headquarters Country
USA
Top Healthcare Companies in USA
Top Pharmaceutical Companies in USA
Nasdaq / NYSE Code
SUPN
Employee Count
575
Employee Count as of Date
As on 2021
Headquarters City/State
Maryland
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
719 Million USD
Annual Operating Income in USD
-62 Million USD
Annual Net Income in USD
-39 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
1,453 Million USD
Total Liabilities in USD
391 Million USD
Total Equity in USD
1,062 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
SUPERNUS PHARMACEUTICALS INC
Yahoo
Yahoo @ Frankfurt
Company Profile
Supernus Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system diseases. The company annual revenue is 392.8 million USD and 464 employees as on 2019. The headquarters is in USA.
IPO Year
2012
Stock Exchange
Nasdaq
Frankfurt
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share